公开(公告)号：DK145342C

公开(公告)日：1983-03-28

申请号：DK50078

申请日：1978-02-03

Applicant: BASF AG

Inventor： FRICKEL F-F ,  HAGEN H ,  OHNSORGE U ,  FRANKE A ,  LENKE D ,  GRIES J ,  LEHMANN H D

IPC: A61K31/428 ,  C07D275/04

Abstract: New aminopropanol derivatives of 4-hydroxy-1,2-benzisothiazole and their addition salts with acids, their preparation, and pharmaceutical formulations which contain the said compounds and may be used for the treatment and prophylaxis of cardiac and circulatory disorders.

公开(公告)号：SE433848B

公开(公告)日：1984-06-18

申请号：SE7801303

申请日：1978-02-03

Applicant: BASF AG

Inventor： FRICKEL F-F ,  HAGEN H ,  OHNSORGE U ,  FRANKE A ,  LENKE D ,  GREIS J ,  LEHMANN H-D

IPC: A61K31/428 ,  C07D275/04

Abstract: New aminopropanol derivatives of 4-hydroxy-1,2-benzisothiazole and their addition salts with acids, their preparation, and pharmaceutical formulations which contain the said compounds and may be used for the treatment and prophylaxis of cardiac and circulatory disorders.

公开(公告)号：SE7801303A

公开(公告)日：1978-08-06

申请号：SE7801303

申请日：1978-02-03

Applicant: BASF AG

Inventor： FRICKEL F-F ,  HAGEN H ,  OHNSORGE U ,  FRANKE A ,  LENKE D ,  GREIS J ,  LEHMANN H-D

IPC: A61K31/428 ,  C07D275/04

CPC classification number: C07D275/04

公开(公告)号：DK145342B

公开(公告)日：1982-11-01

申请号：DK50078

申请日：1978-02-03

Applicant: BASF AG

Inventor： FRICKEL F-F ,  HAGEN H ,  OHNSORGE U ,  FRANKE A ,  LENKE D ,  GRIES J ,  LEHMANN H D

IPC: A61K31/428 ,  C07D275/04

Abstract: New aminopropanol derivatives of 4-hydroxy-1,2-benzisothiazole and their addition salts with acids, their preparation, and pharmaceutical formulations which contain the said compounds and may be used for the treatment and prophylaxis of cardiac and circulatory disorders.

公开(公告)号：SE7801303L

公开(公告)日：1978-08-06

申请号：SE7801303

申请日：1978-02-03

Applicant: BASF AG

Inventor： FRICKEL F-F ,  HAGEN H ,  OHNSORGE U ,  FRANKE A ,  LENKE D ,  GREIS J ,  LEHMANN H-D

IPC: A61K31/428 ,  C07D275/04

Abstract: New aminopropanol derivatives of 4-hydroxy-1,2-benzisothiazole and their addition salts with acids, their preparation, and pharmaceutical formulations which contain the said compounds and may be used for the treatment and prophylaxis of cardiac and circulatory disorders.